Mark Ballow

Summary

Affiliation: State University of New York at Buffalo
Country: USA

Publications

  1. ncbi request reprint Clinical and investigational considerations for the use of IGIV therapy
    Mark Ballow
    Department of Pediatrics, Women and Children s Hospital of Buffalo, SUNY Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Am J Health Syst Pharm 62:S12-8; quiz S19-21. 2005
  2. ncbi request reprint Reliability and validity of the Asthma Trigger Inventory applied to a pediatric population
    Beatrice L Wood
    Woman and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Pediatr Psychol 32:552-60. 2007
  3. ncbi request reprint Depressed children with asthma evidence increased airway resistance: "vagal bias" as a mechanism?
    Bruce D Miller
    Department of Psychiatry, School of Medicine and Biomedical Sciences, State University of New York, Child and Family Asthma Studies Center, Women and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Allergy Clin Immunol 124:66-73.e1-10. 2009
  4. ncbi request reprint Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effect
    Beatrice L Wood
    Woman and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Pediatr Psychol 32:542-51. 2007
  5. doi request reprint The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders
    Mark Ballow
    Allergy Clinical Immunology Division, Department of Pediatrics, Women and Children s Hospital of Buffalo, Buffalo, NY, USA
    J Allergy Clin Immunol 127:315-23; quiz 324-5. 2011
  6. doi request reprint Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases
    Heather K Lehman
    Division of Allergy Immunology, Department of Pediatrics, Women and Children s Hospital of Buffalo, University at Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Clin Rev Allergy Immunol 34:141-5. 2008
  7. ncbi request reprint Biologic immune modifiers: Trials and tribulations--are we there yet?
    Mark Ballow
    Department of Pediatrics, Division of Allergy and Clinical Immunology, Women and Children s Hospital of Buffalo, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY 14222, USA
    J Allergy Clin Immunol 118:1209-15; quiz 1216-7. 2006
  8. doi request reprint Approach to the patient with recurrent infections
    Mark Ballow
    Division of Allergy Clinical Immunology, Department of Pediatrics, Women and Children s Hospital of Buffalo, SUNY Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Clin Rev Allergy Immunol 34:129-40. 2008
  9. ncbi request reprint Safety of IGIV therapy and infusion-related adverse events
    Mark Ballow
    Department of Pediatrics, Women and Children s Hospital of Buffalo, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14222, USA
    Immunol Res 38:122-32. 2007
  10. ncbi request reprint Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
    Jordan S Orange
    Department of Pediatrics, University of Pennsylvania School of Medicine, The Children s Hospital of Philadelphia, Philadelphia 19104, USA
    J Allergy Clin Immunol 117:S525-53. 2006

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Clinical and investigational considerations for the use of IGIV therapy
    Mark Ballow
    Department of Pediatrics, Women and Children s Hospital of Buffalo, SUNY Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Am J Health Syst Pharm 62:S12-8; quiz S19-21. 2005
    ..Case studies are also presented to examine practical considerations in the selection of IGIV products for patients at risk for adverse events...
  2. ncbi request reprint Reliability and validity of the Asthma Trigger Inventory applied to a pediatric population
    Beatrice L Wood
    Woman and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Pediatr Psychol 32:552-60. 2007
    ..To test the reliability and validity of the Asthma Trigger Inventory (ATI) applied to a pediatric population...
  3. ncbi request reprint Depressed children with asthma evidence increased airway resistance: "vagal bias" as a mechanism?
    Bruce D Miller
    Department of Psychiatry, School of Medicine and Biomedical Sciences, State University of New York, Child and Family Asthma Studies Center, Women and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Allergy Clin Immunol 124:66-73.e1-10. 2009
    ..Depression is prevalent in pediatric asthma, and implicated in asthma morbidity and mortality. Pathways linking stress, depression, and asthma are unknown...
  4. ncbi request reprint Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effect
    Beatrice L Wood
    Woman and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Pediatr Psychol 32:542-51. 2007
    ....
  5. doi request reprint The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders
    Mark Ballow
    Allergy Clinical Immunology Division, Department of Pediatrics, Women and Children s Hospital of Buffalo, Buffalo, NY, USA
    J Allergy Clin Immunol 127:315-23; quiz 324-5. 2011
    ..It can now be appreciated that IVIG affects many different pathways to modulate the immune and inflammatory response. Further delineation of these pathways might lead to new treatment strategies...
  6. doi request reprint Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases
    Heather K Lehman
    Division of Allergy Immunology, Department of Pediatrics, Women and Children s Hospital of Buffalo, University at Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Clin Rev Allergy Immunol 34:141-5. 2008
    ..These diseases offer important insights into the mechanisms of central and peripheral immune tolerance and the pathogenesis of defects in these mechanisms...
  7. ncbi request reprint Biologic immune modifiers: Trials and tribulations--are we there yet?
    Mark Ballow
    Department of Pediatrics, Division of Allergy and Clinical Immunology, Women and Children s Hospital of Buffalo, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY 14222, USA
    J Allergy Clin Immunol 118:1209-15; quiz 1216-7. 2006
    ..Nevertheless, as we learn how to modify and alter the inflammatory and immune processes with these new biologic agents, clinicians will enter a new era of treatment options available for their patients with allergic disorders...
  8. doi request reprint Approach to the patient with recurrent infections
    Mark Ballow
    Division of Allergy Clinical Immunology, Department of Pediatrics, Women and Children s Hospital of Buffalo, SUNY Buffalo School of Medicine and Biomedical Sciences, 219 Bryant Street, Buffalo, NY 14222, USA
    Clin Rev Allergy Immunol 34:129-40. 2008
    ..Important details from the history and physical examination, and an appropriate choice of screening laboratory test to be ordered in a given situation are discussed...
  9. ncbi request reprint Safety of IGIV therapy and infusion-related adverse events
    Mark Ballow
    Department of Pediatrics, Women and Children s Hospital of Buffalo, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14222, USA
    Immunol Res 38:122-32. 2007
    ..Availability of IGIV product has been of particular concern to the clinical immunologists who take care of patients with primary immune deficiency disorders since there are no alternative therapies for these patients...
  10. ncbi request reprint Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
    Jordan S Orange
    Department of Pediatrics, University of Pennsylvania School of Medicine, The Children s Hospital of Philadelphia, Philadelphia 19104, USA
    J Allergy Clin Immunol 117:S525-53. 2006
    ..Given the potential risks and inherent scarcity of IGIV, careful consideration of the indications for and administration of IGIV is warranted...
  11. doi request reprint The use of commercially available genetic tests in immunodeficiency disorders
    Heather K Lehman
    Division of Allergy Immunology, Women and Children s Hospital of Buffalo, Buffalo, New York 14222, USA
    Ann Allergy Asthma Immunol 101:212-8. 2008
  12. doi request reprint Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data
    Mark Ballow
    Division of Allergy and Immunology, Women and Children s Hospital of Buffalo, SUNY Buffalo, School of Medicine, Buffalo, New York Department of Pediatrics, Division of Allergy, Immunology and Pediatric Rheumatology, University of South Florida, St Petersburg, Florida Electronic address
    Ann Allergy Asthma Immunol 111:S2-5. 2013
    ..An increasing body of evidence suggests that the optimal dose for IgG replacement therapy is the dose that keeps the patient as free from infection as possible by either intravenous or subcutaneous delivery...
  13. ncbi request reprint Dosing and therapy utilization: a discussion of updates on PI treatment guidelines
    Mark Ballow
    Division of Allergy and Clinical Immunology, Women and Children s Hospital of Buffalo, SUNY Buffalo, School of Medicine, 219 Bryant Street, Buffalo, NY 14222, USA
    J Clin Immunol 32:S415-20. 2012
    ..Decisions regarding the route of therapy should also be individualized to the patient, weighing such factors as side effects, adherence with therapy, and lifestyle...
  14. ncbi request reprint Images in immunodeficiency
    William T Shearer
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    J Allergy Clin Immunol 120:982-4. 2007
  15. ncbi request reprint A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum
    Heather K Lehman
    Division of Allergy Immunology, University of Buffalo School of Medicine and Biomedical Sciences, Women and Children s Hospital of Buffalo, Buffalo, NY 14222, USA
    J Pediatr 152:133-5. 2008
  16. ncbi request reprint Initiation of maintenance antiinflammatory medication in asthmatic children in a pediatric emergency department
    Heather K Lehman
    Division of Allergy and Immunology, Department of Pediatrics, University at Buffalo School of Medicine and Biomedical Sciences, Women and Children s Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222, USA
    Pediatrics 118:2394-401. 2006
    ....
  17. ncbi request reprint Association of depressive symptoms and disease activity in children with asthma: methodological and clinical implications
    James Waxmonsky
    Department of Psychiatry, State University of New York at Buffalo, Buffalo, NY 14222, USA
    J Am Acad Child Adolesc Psychiatry 45:945-54. 2006
    ..This study was designed to assess the prevalence of depressive symptoms in children with asthma and the association between depression and asthma activity...
  18. doi request reprint Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes
    Mark Ballow
    Allergy Clinical Immunology Division, Women and Children s Hospital, 219 Bryant St, Buffalo, NY 14222, USA
    Clin Immunol 139:208-14. 2011
    ..The enhanced differentiation of PBM into DC required two signals: an initial exposure to low concentrations of LPS followed by IVIG. The second signal with IVIG was Fc dependent...
  19. doi request reprint Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposis
    Joel M Bernstein
    Department of Otolaryngology and Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA
    Laryngoscope 121:647-55. 2011
    ..Furthermore, IgE-mediated hypersensitivity directed against these exotoxins produces an additional independent immunologic mechanism in upregulating the inflammatory response in the lateral wall of the nose in nasal polyposis...
  20. ncbi request reprint Intravenous immunoglobulins: clinical experience and viral safety
    Mark Ballow
    Division of Pediatric Allergy Immunology Rheumatology, Children s Hospital of Buffalo, NY 14222, USA
    J Am Pharm Assoc (Wash) 42:449-58; quiz 458-9. 2002
    ....
  21. ncbi request reprint Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial
    Chaim M Roifman
    Division of Immunology Allergy, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8
    Int Immunopharmacol 3:1325-33. 2003
    ..No evidence of viral transmission was observed. IGIV-C appears to be superior to IGIV-SD in preventing validated sinopulmonary infections, especially acute sinusitis, in patients with PID...
  22. ncbi request reprint Progressive muscle weakness in a 4-year-old girl
    Janet B Kim
    Mission Pediatric Medical Clinic, Mission Viejo, California 92691, USA
    Ann Allergy Asthma Immunol 92:19-24. 2004
  23. ncbi request reprint -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
    Mark Ballow
    J Allergy Clin Immunol 116:738-43. 2005
  24. ncbi request reprint Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
    Melvin Berger
    Rainbow Babies and Children s Hospital, Division of Allergy Immunology, 111100 Euclid Avenue, Cleveland, Ohio 44106, USA
    J Clin Immunol 27:503-9. 2007
    ..Serum IgG trough levels were unchanged from baseline. Carimune NF Liquid, a ready-to-use, high-concentration, liquid immunoglobulin preparation is safe and effective...

Research Grants4

  1. VITAMIN A THERAPY IN PRETERM INFANTS: VACCINE RESPONSE
    Mark Ballow; Fiscal Year: 1999
    ..These factors could lead to decreased morbidity and mortality of pre-term infants during early postnatal life. ..
  2. VITAMIN A THERAPY IN PRETERM INFANTS: VACCINE RESPONSE
    Mark Ballow; Fiscal Year: 2000
    ..These factors could lead to decreased morbidity and mortality of pre-term infants during early postnatal life. ..
  3. VITAMIN A THERAPY IN PRETERM INFANTS: VACCINE RESPONSE
    Mark Ballow; Fiscal Year: 2001
    ..These factors could lead to decreased morbidity and mortality of pre-term infants during early postnatal life. ..
  4. VITAMIN A THERAPY IN PRETERM INFANTS: VACCINE RESPONSE
    Mark Ballow; Fiscal Year: 2002
    ..These factors could lead to decreased morbidity and mortality of pre-term infants during early postnatal life. ..